Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Compensated Hypothyroidism"'
Publikováno v:
Клинический разбор в общей медицине, Vol 2, Iss 5, Pp 21-24 (2021)
Statin-associated muscle symptoms are one of the statin-induced side effects. The incidence of the condition is increased by the presence of associated risk factors, one of which is hypothyroidism. The paper reports clinical case of statin-associated
Externí odkaz:
https://doaj.org/article/69d1808f7ac64a41ae3eb9e997c4c675
Autor:
Leonid G. Strongin, Liya A. Lugovaya, Tatyana A. Nekrasova, Tatyana V. Koroleva, Natalya I. Tarasova, Anna B. Novitskaya, Olga V. Ledentsova, Yelena S. Vasileva
Publikováno v:
Клиническая и экспериментальная тиреоидология, Vol 13, Iss 3, Pp 36-44 (2017)
Aim: to assess the influence of compensated hypothyroidism and SLCO1B1 *5 (c.521TC) gene polymorphism on the clinical and laboratory signs of the muscle damage during statin therapy. Methods: assessment of symptoms and markers of the muscle damage
Externí odkaz:
https://doaj.org/article/b5626d882e3e458cac95cc2e61dfed05
Autor:
Giuseppe Crisafulli, Tommaso Aversa, Giuseppina Zirilli, Giovanni Battista Pajno, Domenico Corica, Filippo De Luca, Malgorzata Wasniewska
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
Aim of this mini review was to analyze the main variables which should be taken into account when the decision regarding a possible treatment with L-T4 has to be considered for a child with subclinical hypothyroidism (SH). The indications of periodic
Externí odkaz:
https://doaj.org/article/42615331a106455eb74af4eae799f22e
Publikováno v:
Endocrine
Purpose Hypothyroidism is associated with a lower metabolic rate, impaired glucose tolerance, and increased responsiveness of sympathetic nervous system to glucose ingestion. The Levothyroxine (LT4) monotherapy is the standard treatment for hypothyro
Autor:
Liya A. Lugovaya, Yelena S. Vasileva, Anna B. Novitskaya, T A Nekrasova, Tatyana V. Koroleva, Olga V. Ledentsova, L G Strongin, Natalya I. Tarasova
Publikováno v:
Клиническая и экспериментальная тиреоидология, Vol 13, Iss 3, Pp 36-44 (2017)
Aim : to assess the influence of compensated hypothyroidism and SLCO1B1 *5 (c.521T>C) gene polymorphism on the clinical and laboratory signs of the muscle damage during statin therapy. Methods: assessment of symptoms and markers of the muscle damage
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giuseppina Zirilli, Malgorzata Wasniewska, Giuseppe Crisafulli, Filippo De Luca, Tommaso Aversa, Domenico Corica, Giovanni Battista Pajno
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 10 (2019)
Frontiers in Endocrinology, Vol 10 (2019)
Aim of this mini review was to analyze the main variables which should be taken into account when the decision regarding a possible treatment with L-T4 has to be considered for a child with subclinical hypothyroidism (SH). The indications of periodic
Autor:
Cédric O Renaud, Klaudia Brix, Ioannis Habeos, Massimo Bongiovanni, Peter Kopp, Xiao Hui Liao, Gerasimos P. Sykiotis, Dionysios V. Chartoumpekis, Panos G. Ziros, Samuel Refetoff
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 11 (2020)
Frontiers in Endocrinology, Vol 11 (2020)
Background: Autoimmune thyroiditis (AIT) is the most common cause of acquired hypothyroidism in children. The natural outcome of AIT in childhood has been reported previously however follow-up duration is generally short and results variable. Objecti
Autor:
Peter Kopp, Klaudia Brix, Gerasimos P. Sykiotis, Panos G. Ziros, Xiao Hui Liao, Massimo Bongiovanni, Dionysios V. Chartoumpekis, Cédric O Renaud, Samuel Refetoff, Ioannis Habeos
Publikováno v:
Journal of the Endocrine Society
Background: Familial non-toxic multinodular goiter (MNG) is a rare disease. KEAP1 gene (Kelch-like ECH-associated protein 1) that encodes the main inhibitor of nuclear factor erythroid 2-related transcription factor 2 (Nrf2), a central mediator of an